Aditi Puri, MD, MS
![1]() - News- Efficacy of DOACs vs. warfarin in high-risk atrial fibrillation patients- July 25, 2019- Are the direct-acting anticoagulants (DOACs) rivaroxaban and dabigatran efficacious and safe, compared with warfarin, in elderly atrial fibrillation patients with new-onset atrial fibrillation and multiple major comorbidities? 
![1]() - News- Do prophylactic PPIs improve mortality in critically ill patients?- July 25, 2019- Does the use of prophylactic proton pump inhibitors improve mortality or cause more adverse events in critically ill ICU patients at high risk of gastrointestinal bleeding? 

